Reengineered cyclic small-molecule Type XVII Collagen boasts a stable structure that delivers long-lasting, non-degrading effects. With built-in penetration-enhancing properties, it improves transdermal absorption, targets and binds to integrin β1, and effectively promotes the upregulation of key collagen expression in the dermal-epidermal junction (DEJ) and the dermis.